PubMed:33100292
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T1 | 1006-1014 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
T2 | 1414-1420 | Body_part | denotes | saliva | http://purl.org/sig/ont/fma/fma59862 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T1 | 1249-1254 | Body_part | denotes | scale | http://purl.obolibrary.org/obo/UBERON_0002542 |
T2 | 1414-1420 | Body_part | denotes | saliva | http://purl.obolibrary.org/obo/UBERON_0001836 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 90-98 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T2 | 148-156 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T3 | 262-270 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T4 | 507-515 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T5 | 794-802 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T6 | 865-873 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T7 | 906-914 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T8 | 1295-1303 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T9 | 1306-1315 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 19-20 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T2 | 65-66 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T3 | 170-171 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T4 | 193-196 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T5 | 395-397 | http://purl.obolibrary.org/obo/CLO_0001302 | denotes | 34 |
T6 | 1175-1176 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
T7 | 1217-1224 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | testing |
T8 | 1477-1478 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T9 | 1658-1659 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T1 | 726-737 | Chemical | denotes | chloroquine | http://purl.obolibrary.org/obo/CHEBI_3638 |
T2 | 739-750 | Chemical | denotes | favipiravir | http://purl.obolibrary.org/obo/CHEBI_134722 |
T3 | 752-762 | Chemical | denotes | remdesivir | http://purl.obolibrary.org/obo/CHEBI_145994 |
T4 | 773-778 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
T5 | 839-843 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T6 | 1204-1216 | Chemical | denotes | nucleic acid | http://purl.obolibrary.org/obo/CHEBI_33696 |
T7 | 1212-1216 | Chemical | denotes | acid | http://purl.obolibrary.org/obo/CHEBI_37527 |
T8 | 1550-1555 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
T9 | 1675-1683 | Chemical | denotes | solution | http://purl.obolibrary.org/obo/CHEBI_75958 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
1 | 90-98 | Disease | denotes | COVID-19 | MESH:C000657245 |
14 | 124-146 | Disease | denotes | coronavirus disease 19 | MESH:C000657245 |
15 | 148-156 | Disease | denotes | COVID-19 | MESH:C000657245 |
16 | 262-270 | Disease | denotes | COVID-19 | MESH:C000657245 |
17 | 507-515 | Disease | denotes | COVID-19 | MESH:C000657245 |
18 | 726-737 | Chemical | denotes | chloroquine | MESH:D002738 |
19 | 739-750 | Chemical | denotes | favipiravir | MESH:C462182 |
20 | 752-762 | Chemical | denotes | remdesivir | MESH:C000606551 |
21 | 794-802 | Disease | denotes | COVID-19 | MESH:C000657245 |
22 | 865-873 | Disease | denotes | COVID-19 | MESH:C000657245 |
23 | 906-916 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
24 | 1281-1289 | Species | denotes | patients | Tax:9606 |
25 | 1295-1315 | Disease | denotes | SARS-CoV-2 infection | MESH:C000657245 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-99 | Sentence | denotes | The development of a quarantine strategy is an important path to a normalized response to COVID-19. |
T2 | 100-230 | Sentence | denotes | The ongoing pandemic of coronavirus disease 19 (COVID-19) is still in a global pandemic that has affected more than 200 countries. |
T3 | 231-384 | Sentence | denotes | When prevention and control of COVID-19 is gradually normalized, communication between countries needs to be gradually restored due to development needs. |
T4 | 385-701 | Sentence | denotes | There are 34 vaccines in the clinical evaluation stage and 145 vaccines in the preclinical evaluation stage in the global COVID-19 vaccine research and development program, but the rate and process of vaccination may not be sufficient to meet the current needs of society for restoring development and communication. |
T5 | 702-874 | Sentence | denotes | Studies have found that chloroquine, favipiravir, remdesivir and other drugs are useful for COVID-19, but currently there is no specific drug for the treatment of COVID-19. |
T6 | 875-1114 | Sentence | denotes | The main detection methods for SARS-CoV-2 at present include pathogenic detection methods, molecular biology detection methods and antibody detection, of which molecular biology detection technology is the main detection method at present. |
T7 | 1115-1174 | Sentence | denotes | There are some more convenient and rapid detection methods. |
T8 | 1175-1450 | Sentence | denotes | A study showed that salivary nucleic acid testing could be used for large-scale screening of asymptomatic patients with SARS-CoV-2 infection, and the results showed that the probability of true concordance between nasopharyngeal swabs and saliva was stubbornly 0.998 (90% CI: |
T9 | 1451-1464 | Sentence | denotes | 0.996-0.999). |
T10 | 1465-1759 | Sentence | denotes | At present, a vaccine is still not widely available, and the development of specific drugs will take some time, so prioritizing quarantine countermeasures on the premise of cost control may be a more important solution for the recovery and development of normal communication between countries. |